Fulgent Genetics
Fulgent Genetics, a leading player in the genetic testing industry, is headquartered in the United States. Founded in 2016, the company has rapidly established itself as a key provider of comprehensive genomic solutions, focusing on areas such as hereditary cancer testing, infectious disease testing, and pharmacogenomics. Fulgent's innovative approach combines advanced technology with a broad test menu, offering unique, customisable panels that cater to diverse clinical needs. The company has achieved significant milestones, including partnerships with healthcare providers and laboratories, enhancing its market position. With a commitment to accuracy and efficiency, Fulgent Genetics continues to drive advancements in precision medicine, making a notable impact in the field of genomics.
DitchCarbon Score
How does Fulgent Genetics's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Fulgent Genetics's score of 43 is higher than 95% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Fulgent Genetics's reported carbon emissions
In 2023, Fulgent Genetics reported total carbon emissions of approximately 4,528,000 kg CO2e, comprising 576,000 kg CO2e from Scope 1 and 3,953,000 kg CO2e from Scope 2 emissions. This marks a significant increase from 2022, where total emissions were about 6,562,000 kg CO2e, with Scope 1 at 2,130,000 kg CO2e and Scope 2 at 4,433,000 kg CO2e. In 2021, the company emitted approximately 3,101,000 kg CO2e, with Scope 1 emissions at 1,651,000 kg CO2e and Scope 2 at 1,450,000 kg CO2e. Fulgent Genetics has set ambitious climate commitments, aiming to achieve net zero emissions by 2050. Additionally, the company plans to reduce its emissions by 45% by 2030 compared to 2010 levels. These targets reflect a proactive approach to addressing climate change and reducing their overall carbon footprint across all scopes of emissions.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 1,651,000 | 0,000,000 | 000,000 |
| Scope 2 | 1,450,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Fulgent Genetics is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
